These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11816835

  • 1. Leflunomide Aventis Pharma.
    Kaplan MJ.
    Curr Opin Investig Drugs; 2001 Feb; 2(2):222-30. PubMed ID: 11816835
    [Abstract] [Full Text] [Related]

  • 2. Etanercept Immunex.
    Yung RL.
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [Abstract] [Full Text] [Related]

  • 3. Etanercept. Immunex.
    Pugsley MK.
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1725-31. PubMed ID: 11892935
    [Abstract] [Full Text] [Related]

  • 4. Tezacitabine Hoechst Marion Roussel.
    Seley KL.
    Curr Opin Investig Drugs; 2000 Sep; 1(1):135-40. PubMed ID: 11249589
    [Abstract] [Full Text] [Related]

  • 5. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [Abstract] [Full Text] [Related]

  • 6. Safety evaluation of leflunomide in rheumatoid arthritis.
    Keen HI, Conaghan PG, Tett SE.
    Expert Opin Drug Saf; 2013 Jul; 12(4):581-8. PubMed ID: 23668332
    [Abstract] [Full Text] [Related]

  • 7. Cariporide Aventis.
    Chin B, Lip GY.
    Curr Opin Investig Drugs; 2000 Nov; 1(3):340-6. PubMed ID: 11249717
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
    Smolen JS, Emery P, Kalden JR, Van Riel PL, Dougados M, Strand CV, Breedveld FC.
    J Rheumatol Suppl; 2004 Jun; 71():13-20. PubMed ID: 15170903
    [Abstract] [Full Text] [Related]

  • 9. Valdecoxib (Pharmacia).
    Gotta AW.
    Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
    [Abstract] [Full Text] [Related]

  • 10. Telithromycin. Aventis Pharma.
    Johnson AP.
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1691-701. PubMed ID: 11892930
    [Abstract] [Full Text] [Related]

  • 11. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis.
    Alldred A, Emery P.
    Expert Opin Pharmacother; 2001 Jan; 2(1):125-37. PubMed ID: 11336574
    [Abstract] [Full Text] [Related]

  • 12. Exubera. Inhale therapeutic systems.
    Bindra S, Cefalu WT.
    Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
    [Abstract] [Full Text] [Related]

  • 13. Leflunomide.
    Cannon GW, Kremer JM.
    Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
    [Abstract] [Full Text] [Related]

  • 14. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
    Kalden JR, Schattenkirchner M, Sörensen H, Emery P, Deighton C, Rozman B, Breedveld F.
    Arthritis Rheum; 2003 Jun; 48(6):1513-20. PubMed ID: 12794818
    [Abstract] [Full Text] [Related]

  • 16. Leflunomide in clinical practice.
    Pinto P, Dougados M.
    Acta Reumatol Port; 2006 Jun; 31(3):215-24. PubMed ID: 17094333
    [Abstract] [Full Text] [Related]

  • 17. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P, Kiely P, Kirkham B, Lawson T, Moots R, Proudfoot D, Reece R, Scott D, Sword R, Taggart A, Thwaites C, Williams E.
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [Abstract] [Full Text] [Related]

  • 18. Leflunomide for the treatment of rheumatoid arthritis.
    Olsen NJ, Strand V, Kremer JM.
    Bull Rheum Dis; 1999 Mar; 48(8):1-4. PubMed ID: 10628065
    [Abstract] [Full Text] [Related]

  • 19. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
    Suissa S, Hudson M, Ernst P.
    Arthritis Rheum; 2006 May; 54(5):1435-9. PubMed ID: 16645972
    [Abstract] [Full Text] [Related]

  • 20. Leflunomide: a drug with a potential beyond rheumatology.
    Teschner S, Burst V.
    Immunotherapy; 2010 Sep; 2(5):637-50. PubMed ID: 20874647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.